Role of adjuvant therapy in the management of pancreatic cancer

Adv Surg. 2005:39:223-44. doi: 10.1016/j.yasu.2005.05.003.

Authors

Dan Laheru¹, Charles J Yeo

Affiliation

¹ Department of Medical Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.

PMID: 16250554
DOI: 10.1016/j.yasu.2005.05.003

No abstract available

Publication types

Review

MeSH terms

Adenocarcinoma / drug therapy*
Adenocarcinoma / radiotherapy*
Antimetabolites, Antineoplastic / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cancer Vaccines / therapeutic use
Chemotherapy, Adjuvant
Fluorouracil / therapeutic use
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
Humans
Immunotherapy
Neoadjuvant Therapy
Pancreatic Neoplasms / drug therapy*
Pancreatic Neoplasms / mortality
Pancreatic Neoplasms / radiotherapy*
Pancreatic Neoplasms / surgery
Radiotherapy Dosage
Radiotherapy, Adjuvant

Substances

Antimetabolites, Antineoplastic
Cancer Vaccines
Granulocyte-Macrophage Colony-Stimulating Factor
Fluorouracil